Cancer Patients Give Regional Cancer Care Associates (RCCA) High Marks in Patient-Satisfaction Surveys
Share on facebook Share on twitter Share on linkedin Share on email Share on print Patient-satisfaction ratings from the Oncology
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Share on facebook Share on twitter Share on linkedin Share on email Share on print Patient-satisfaction ratings from the Oncology
Share on facebook Share on twitter Share on linkedin Share on email Share on print Doctors are at the forefront
Leukemia diagnoses are rising in northern New Jersey even as they fall nationwide, with Sussex and Morris counties outpacing the
HER2-positive and triple-negative breast cancer are among the most aggressive forms of breast cancer and traditionally have had lower survival
Share on facebook Share on twitter Share on linkedin Share on email Share on print While lung cancer remains the
Recent FDA actions have significantly expanded treatment options for women with advanced uterine cancer, according to two oncologists with Regional
A look at who is a candidate for genetic screening, and how that screening should be performed.
Three RCCA oncologists look at the factors driving this troubling trend.
The numbers are cause for awareness and proactivity, not anxiety, Dr. Levenbach explains.
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.